瑞士纳沙泰尔--(美国商业资讯)--Masimo (NASDAQ: MASI)今天发布可用于Root的双联SET脉搏氧饱和度仪,Root是一款功能丰富的多用型患者监护和联网中心设备。双联SET氧饱和度仪的率先应用是依据Masimo SET进行的危重型先天性心脏病(CCHD)筛查的一次重大进步,已获得CE认证 ...
当地时间11月8日,GE医疗和Masimo共同宣布了一项联合协议:将Masimo脉搏血氧饱和度监测信号提取技术(SET)集成到GE医疗最近获批的Portrait Mobile无线可穿戴监测系统中。 Portrait Mobile 据了解,Portrait Mobile是首创的无线检测解决方案,不仅能够实时连续监测患者生命 ...
瑞士纳沙泰尔--(BUSINESS WIRE)----(美国商业资讯)--Masimo(NASDAQ: MASI)提供旨在加强分娩和出生后关键的前几分钟内孕产妇和新生儿安全的各种创新监护解决方案。Masimo SET ® 脉搏氧饱和度仪能在移动和低灌注下测量,服务于新生儿、初生儿和儿科患者,而其他脉搏氧 ...
(美国商业资讯) -- Masimo (NASDAQ: MASI)今天发布了最近发表的一项研究结果,该研究中,研究人员调查居家脉搏氧饱和度仪监测能否作为有用的初步筛查方法,用于确定推荐哪些唐氏综合征 (DS)患儿通过多通道睡眠检查来诊断该病,DS患儿是阻塞性睡眠呼吸暂停 (OSA)的高危人群。居家监测采 ...
Zacks.com on MSN
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...
Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
The INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility Study Showed No Clinically Significant Bias Between Patients with Light ...
Introduction: Neonatal transport presents challenges for physiological monitoring. Vibration and acceleration can cause motion artefact. Signal loss or inaccuracy could lead to unnecessary ...
The surveillance monitoring system provided continuous monitoring using Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, and was comprised of Masimo Radical-7® and Rad-87® Pulse ...
Masimo CorporationMASI recently announced that India-based Cloudnine Hospital Group has taken up Masimo SET technology to monitor infants suffering from Critical Congenital Heart Disease (CCHD). CCHD ...
Masimo Corp.’s pulse oximetry technology avoids the dangerous under-recognition of low oxygen levels in people of color that plagues many pulse oximeters on the market, a peer-reviewed study in the ...
Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果